Skip to content
Clinical Trials – home
HungaryBack to Hungary

Clinical trials in Pecs – page 23

346 clinical trials in Pecs, Hungary across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Pecs at a glance
346
clinical trials
  • Research sites3
Type of trial
Recruitment status
Quick filters

346 trials in Pecs

Open in trial search

Malignant melanoma

Not recruiting

Study of Fianlimab and Cemiplimab for Patients with Untreated Advanced Melanoma

Registered drug
Countries:HungaryHungary
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Cemiplimab
  • Sponsor:Regeneron Pharmaceuticals Inc.

Chronic kidney disease+1

Not recruiting

Study on Finerenone for Children with Chronic Kidney Disease and Proteinuria Using ACEI or ARB

Investigational
Countries:HungaryHungary
  • Participants:0–17 years
  • Substances:Finerenone
  • Sponsor:Bayer AG

Alopecia areata

Not recruiting

Study on the Safety and Effectiveness of Upadacitinib for Adults and Adolescents with Severe Alopecia Areata

Investigational
Countries:HungaryHungary
  • Participants:0–17 years · 18–64 years
  • Substances:Upadacitinib
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Asthma

Not recruiting

Study on the Effectiveness and Safety of Fluticasone Propionate and Salbutamol Sulfate for Patients with Asthma

InvestigationalNo placebo
Countries:HungaryHungary
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Salbutamol Sulfate
  • Sponsor:Teva Branded Pharmaceutical Products R&D LLC

Study on the Effectiveness and Safety of Litifilimab for Patients with Active Subacute or Chronic Cutaneous Lupus Erythematosus Resistant to Antimalarial Therapy

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Litifilimab
  • Sponsor:Biogen Idec Research Limited

Study of OP-1250 for Treating Advanced or Metastatic ER+, HER2- Breast Cancer in Patients After Endocrine and CDK4/6 Inhibitor Therapy

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Olema Pharmaceuticals Inc.

Hypertension

Not recruiting

Study on Baxdrostat for Lowering Blood Pressure in Patients with Resistant Hypertension

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Ponsegromab
  • Sponsor:Pfizer Inc.

Study of VRDN-001 for Patients with Thyroid Eye Disease Who Did Not Respond to Previous Treatment

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Viridian Therapeutics Inc.

Study on AVP-786 for Treating Agitation in Alzheimer's Dementia Patients

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Quinidine Sulfate
  • Sponsor:Otsuka Pharmaceutical Development & Commercialization Inc.

Study on Atezolizumab for Patients with Non-Small Cell Lung Cancer After Chemotherapy

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:F. Hoffmann-La Roche AG

Study of IO102-IO103 and Pembrolizumab for Patients with Advanced Melanoma

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:IO102 hydrochloride
  • Sponsor:Io Biotech ApS

Other cities in Hungary

The busiest research cities in the country

All 71 cities in Hungary

Clinical research in Pecs

What the registry says about research in the country

01 Respiratory Conditions

Clinical research focusing on innovative treatments for chronic rhinosinusitis and asthma, with studies evaluating new therapeutic approaches for both conditions with and without nasal polyps.

  • Uncontrolled Asthma Management
  • Nasal Polyps Treatment
  • Viral Lung Infections

Multiple trials investigating novel medications to improve respiratory symptoms and patient quality of life.

02 Cardiovascular Research

Groundbreaking studies in heart failure prevention and cardiomyopathy, exploring new therapeutic options for various cardiovascular conditions.

  • Heart Failure Risk Reduction
  • Hypertrophic Cardiomyopathy
  • Cardiovascular Disease Prevention

Advanced research aimed at reducing cardiovascular events and improving patient outcomes.

03 Autoimmune Disorders

Innovative research into treatments for systemic sclerosis and Sjögren's syndrome, focusing on novel therapeutic approaches for these challenging conditions.

  • Systemic Sclerosis Management
  • Primary Sjögren's Disease
  • Autoimmune Manifestations

Studies evaluating new biological treatments to address various autoimmune conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.